✦ LIBER ✦

REVIEW: γ-Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

✍ Scribed by Francesco Panza; Vincenza Frisardi; Bruno P. Imbimbo; Cristiano Capurso; Giancarlo Logroscino; Daniele Sancarlo; Davide Seripa; Gianluigi Vendemiale; Alberto Pilotto; Vincenzo Solfrizzi

Book ID: 118076713
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 212 KB
Volume: 16
Category: Article
ISSN: 1755-5930
DOI: 10.1111/j.1755-5949.2010.00164.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

γ-secretase inhibitors for the treatment

γ-secretase inhibitors for the treatment of Alzheimer's disease

✍ Wen-Lian Wu; Lili Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Advances in the identification of γ-secr

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

✍ D'Onofrio, Grazia; Panza, Francesco; Frisardi, Vincenza; Solfrizzi, Vincenzo; Im 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 457 KB

At the frontline of Alzheimer’s disease

At the frontline of Alzheimer’s disease treatment: γ-secretase inhibitor/modulator mechanism

✍ Taisuke Tomita 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

β-secretase inhibitors for treatment of

β-secretase inhibitors for treatment of Alzheimer's disease

✍ O'Neill, Brian T.; Brodney, Michael A.; Ambroise, Claude; Borzilleri, Kris; Coff 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Developing β-secretase inhibitors for tr

Developing β-secretase inhibitors for treatment of Alzheimer’s disease

✍ Arun K. Ghosh; Margherita Brindisi; Jordan Tang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Development of semagacestat (LY450139),

Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease

✍ Henley, David B; May, Patrick C; Dean, Robert A; Siemers, Eric R 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 335 KB